Open Access
Research
(Published
online: 17-11-2016)
17.
Benefits of pomegranate (Punica
granatum
Linn) fruit extracts to weight changes, total protein, and uric
acid in white rats (Rattus
norvegicus)
as an animal model of acute renal failure -
Hardany Primarizky, Wiwik Misaco Yuniarti and Bambang Sektiari
Lukiswanto
Veterinary World, 9(11): 1269-1274
doi:
10.14202/vetworld.2016.1269-1274
Hardany Primarizky:
Department of Veterinary Clinic, Faculty of Veterinary Medicine,
Universitas Airlangga, Surabaya, East Java, Indonesia;
kikken.zeyra@gmail.com
Wiwik Misaco Yuniarti:
Department of Veterinary Clinic, Faculty of Veterinary Medicine,
Universitas Airlangga, Surabaya, East Java, Indonesia; wiwikmisaco@yahoo.com
Bambang Sektiari Lukiswanto:
Department of Veterinary Clinic, Faculty of Veterinary Medicine,
Universitas Airlangga, Surabaya, East Java, Indonesia; bamsekti@yahoo.com
Received: 21-03-2016, Accepted: 13-10-2016, Published online:
17-11-2016
Corresponding author:
Hardany Primarizky, e-mail: kikken.zeyra@gmail.com
Citation:
Primarizky H, Yuniarti WM, Lukiswanto BS (2016) Benefits of
pomegranate (Punica
granatum
Linn) fruit extracts to weight changes, total protein, and uric
acid in white rats (Rattus
norvegicus)
as an animal model of acute renal failure,
Veterinary World, 9(11):
1269-1274.
Abstract
Aim:
The occurrence of acute renal failure (ARF) cases continues to
increase every year. Some of the cases are due to nephrotoxic
effect caused by overdose of antibiotic consumption or abuse of
the drug, gentamicin. An antibiotic therapy that can be used to
overcome in such a case is the pomegranate extracts. However,
until now, studies using pomegranate for cases of ARF have not
been done. This study aims to determine changes in body weight,
the levels of total protein (TP), and the levels of serum uric
acid (UA) as a result of the pomegranate extract consumption.
Materials and Methods:
A
total number of 32 rats (Rattus
norvegicus)
were divided into four groups randomly. One group was assigned as
the control group (P0) and given intraperitoneal (i.p.) saline and
0.3% carboxy methyl cellulose sodium (CMC) Na; P1 was provided
with 80 mg/kg bw/i.p. gentamicin and 0.3% CMC Na orally, P2 was
supplied with 80 mg/kg bw/i.p. gentamicin and ellagic acid in 0.3%
CMC Na, and P3 was given 80 mg/kg bw/i.p. gentamicin and 150 mg/kg
bw pomegranate extract in 0.3% CMC Na. The provision of treatment
was carried out in 8 days and followed by making the overthrow of
body weight and blood sampling for the examination of study
variables.
Results:
The results taken by doing the analysis of variance method for the
four treatment groups show that the control group (P0) has
significant differences from P1, P2, and P3 (p<0.05), but there
are no significant differences among the other three treatment
groups. Meanwhile, the average values of serum UA levels among P1,
P2, and P3 indicate significant differences.
Conclusion:
In conclusion, the administration of pomegranate extracts in the
treatment of nephrotoxicity toward rats is effective to maintain
normal body weight, normal TP levels, and the UA blood serum of
the rats. As this study is a preventive therapy, it needs further
researches about the effective dose as a curative therapy, its
level of effectiveness and its long-term side effects.
Keywords:
acute renal failure, gout, pomegranate extract, total protein.
References
1. Day, R.A., Beverly, W. and Pauline, P. (2009) Brunner and
Suddarth's Textbook of Canadian Medical-Surgical Nursing. 6th
ed. Lippincott and Wilkins, USA. |
|
2. Tambayong, J. (2001) Patofisiologi. Penerbit Buku
Kedokteran, ECG, Jakarta. |
|
3. Bartges, J. and David, J.P. (2011) Nephrology and Urology
of Small Animals. 1st ed. Willey-Blackwell, UK.
https://doi.org/10.1002/9781118785546 |
|
4. Sutardjo, B. and Fransisca, K. (2012) Dialife Magazine:
Kidney Health Information Bulletin. June-July Edition 2012.
PMid:22361136 PMCid:PMC3294181 |
|
5. Eurel, J.A. and Brian, L.F. (2006) Textbook of Veterinary
Histology. 6th ed. Blackwell Publishing, Asia. |
|
6. Guyton, A.C. and Hall, J.E. (2006) Textbook of Medical
Phisiology. 11th ed. WB Saunders Co., Philadelphia, PA.
p859-864. |
|
7. Ganong, W.F. (2001) Review of Medical Physiology.
McGraw-Hill Companies, Inc., San Fransisco. p675-678. |
|
8. Junquiera, L.C. and Carneiro, L. (2003) Basic Histology:
Text & Atlas. 10th ed. The McGraw-Hill Companies Inc., New
York. |
|
9. Bijanti, R., Yuliati, M.G.A., Wahjuni, R.S. and Utomo, R.B.
(2010) Buku Ajar Patologi Klinik Veteriner. Edisi Pertama.
Airlangga University Press, Surabaya. |
|
10. Lansky, E.P. and Newman, R.A. (2007) Review: Punica
granatum (pomegranate) and its potential for prevention and
treatment of inflamation and cancer. J. Ethnopharmacol.,
109(2): 177-206.
https://doi.org/10.1016/j.jep.2006.09.006
PMid:17157465 |
|
11. Budka, D. (2008) Active Ingredients, Their Bioavailibility
and the Health Benefits of the Punica granatum Linn
(Pomegranate). MSML Research Unit, London. |
|
12. Seeram, N.P., Adam, L.S., Henning, S.M., Niu, Y., Zhang,
Y., Nair, M.G. and Heber, D. (2005) In vitro antiproliverative,
apoptotic, and antioxidant activities of punicalagin, ellagic
acid and a total pomegranate tannin extract are enhanced in
combination with other polyphenols as found in pomegranate
juice. J. Nutr. Biochem., 16: 360-367.
https://doi.org/10.1016/j.jnutbio.2005.01.006
PMid:15936648 |
|
13. Koka, R.M., Huang, E. and Lieske, J.C. (2000) Adhesion of
uric acid crystals to the surface of renal epithelial cells.
Am. J. Physiol. Renal Physiol., 278: F989-F998.
PMid:10836987 |
|
14. Verdecchia, P., Schillaci, G., Reboldi, G.P., Santeusanioa,
F., Porcellati, C. and Brunetti, P. (2000) Relation between
serum uric acid and risk of cardiovascular disease in
essential hypertension; the PIUMA study. Hypertension, 36:
1072-1078.
https://doi.org/10.1161/01.HYP.36.6.1072
PMid:11116127 |
|
15. Mazzali, M., Hughes, J., Kim, Y.G., Jefferson, J.A., Kang,
D.H., Gordon, K.L., Lan, H.Y., Kivlighn, S. and Johnson, R.J.
(2001) Elevated uric acid increases blood pressure in the rat
by a novel crystal-independent mechanism. Hypertension, 38:
1101-1106.
https://doi.org/10.1161/hy1101.092839
PMid:11711505 |
|
16. Kang, D.H., Nakagawa, T., Feng, L., Watanabe, S., Han, L.,
Mazzali, M., Truong, L., Harris, R. and Johnson, R.J. (2002) A
role for uric acid in the progression of renal disease. J. Am.
Soc. Nephrol., 13: 2888-2897.
https://doi.org/10.1097/01.ASN.0000034910.58454.FD
PMid:12444207 |
|
17. Singh, A.P., Muthuraman, A., Jaggi, A.S., Singh, N.,
Grover, K. and Dhawan, R. (2012) Review: Animal models of
acute renal failure. Pharmacol. Rep., 64: 31-44.
https://doi.org/10.1016/S1734-1140(12)70728-4 |
|
18. Mahurkar, N., Mumtaz, M. and Ifthekar, S. (2012)
Protective effect of aqueous and methanolic extracts of
Lagenaria siceraria seeds in gentamicin induced nephrotoxicity.
Int. J. Res. Ayurveda Pharm., 3(3): 443-446. |
|
19. Avdagic, N., Cosovic, E., Nakas-Icindic, E., Mornjakovic,
Z., Zaciragic, A. and Hadzovic-Dzuvo, A. (2008) Spirulina
platensis protects against renal injury in rats with
gentamicin-induced acute tubular necrosis. Bosn. J. Basic
Med., 8(4): 331-336. |
|
20. Soenanto, H. (2005) Musnahkan Penyakit Dengan Tanaman Obat.
Puspa Swara, Jakarta. |
|
21. Palanysamy, D., Kannan, S.E. and Bhojraj, S. (2007)
Protective and therapeutic effects of the Indian medicinal
plant Pterocarpus santalinus on D-galactosamine-induced liver
damage. Asian J. Tradit. Med., 2(2): 51-57. |
|
22. Ibrahim, M.A.L. and Sayed, A.A.S. (2012) Comparative study
of quercetin or/and urate oxidase against gentamicin-induced
nephrotoxicity and oxidative stress in rat kidneys. J. Am. Sci.,
8(1): 600-607. |
|
23. Roche (2010). Available from: http://www.roche-applied-science.com/wcsstore/CBCatalogAssetStore/Articles/05837880900_03.11.pdf.
. Last accessed on 07-09-2013. |
|
24. Dalimunthe, A.(2008) Monitoring Effectiveness of Multiple
Intravenous Dose of Gentamicin Against Pneumonia Patients
Community at Center General Hospital H. Adam Malik. Thesis.
University of North Sumatera, Medan. Indonesia. |
|
25. Toblli, J.E., Bevione, P., Di Gennaro, F., Madalena, L.,
Cao, G. and Angerosa, M. (2012) Review article; understanding
the mechanisms of proteinuria: Therapeutic implications. Int.
J. Nephrol., 2012: 1-13.
https://doi.org/10.1155/2012/546039
PMid:22844592 PMCid:PMC3398673 |
|
26. Seeram, N.P., Schulman, R.N. and Heber, D. (2006)
Pomegranate Ancient Roots to Modern Medicine. 1st ed. Taylor
and Francis Group, New York. p2-99. |
|
27. Zhang, Y., Wang, D., Lee, R., Henning, S.M. and Heber, D.
(2009) Absence of pomegranate ellagitannins in the majority of
commercial pomegranate extract: Implications for
standardization and quality control. J. Agric. Food Chem.,
57(16): 7395-7400.
https://doi.org/10.1021/jf9010017
PMid:20349921 |
|